Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
Current Topics in Behavioral Neurosciences|December 3, 2016
Orexin OX2 Receptor Antagonists as Sleep AidsLaura H Jacobson, Sui Chen, Sanjida Mir, et al.
Science (New York, N.Y.)|February 24, 2022
Losing sleep with ageLaura H Jacobson, Daniel Hoyer
Neuropeptides|November 13, 2013
Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?Daniel Hoyer, Laura H Jacobson
British Journal of Clinical Pharmacology|November 23, 2019
Hypnotics with novel modes of actionDaniel Hoyer, Andrew Allen, Laura H Jacobson
Expert Review of Clinical Pharmacology|October 17, 2014
Suvorexant for the treatment of insomniaLaura H Jacobson, Gabrielle E Callander, Daniel Hoyer
Journal of Internal Medicine|January 19, 2022
Hypocretins (orexins): The ultimate translational neuropeptidesLaura H Jacobson, Daniel Hoyer, Luis de Lecea
Journal of Psychopharmacology (Oxford, England)|September 9, 2025
Rapid eye movement sleep: Who needs it? Creativity mechanisms and psychiatric applications of REM sleep enhancementJamie G Elliott, Jeremy A Metha, Daniel Hoyer, et al.
Behavioural Brain Research|June 8, 2025
Investigating the effects of orexin receptor 1 antagonism on decision making under uncertaintyJeremy A Metha, Mathilde Bertheau, Carsten Murawski, et al.
British Journal of Pharmacology|February 3, 2019
Sex differences in mouse models of fear inhibition: Fear extinction, safety learning, and fear-safety discriminationJacob W Clark, Sean P A Drummond, Daniel Hoyer, et al.
Annual Review of Pharmacology and Toxicology|September 14, 2023
Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and DiseaseJarrah O-Z J Kron, Ryan J Keenan, Daniel Hoyer, et al.
Pageof 26